A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance
about
MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect.Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.Phototriggerable peptidomimetics for the inhibition of Mycobacterium tuberculosis ribonucleotide reductase by targeting protein-protein binding.The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In VitroA Selective Small Molecule DNA2 Inhibitor for Sensitization of Human Cancer Cells to ChemotherapyTargeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphomaIdentification of Non-nucleoside Human Ribonucleotide Reductase ModulatorsAutophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells.Replication stress and cancer: it takes two to tango.Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair.Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.Ribonucleotide reductases: essential enzymes for bacterial life.Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma.Cell Cycle Inhibition To Treat Sleeping SicknessInhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
P2860
Q33866466-A58C619E-C2B2-47FF-95A8-4AFB99C98F71Q34227409-316E234C-1411-4CC5-9078-2D621515E943Q35541515-709AAF1D-DC40-4F38-A5DB-6EB7CFD92153Q35600390-B192F8E6-1FA8-4B9A-BD29-A5AAD74A2108Q36025829-D0377CFE-8DFD-44F7-93E3-AEDB535A1C57Q36406993-8F6C446B-6BE6-49DA-B658-2050BF3DE72EQ36575539-B9B6FC04-B1BC-4955-8DEB-91A9C46DFE04Q36739017-488869F0-9EE5-43B7-848A-DCA28153E3B6Q36931593-2C4B6D29-51B8-4824-82A9-0DF03449D697Q37174956-70F4C5C9-07BB-4692-A355-A221C76DB4EAQ37665228-19D1E08E-DDAC-41EF-B51B-A174CAA17810Q38210214-A6D49E2C-F060-4018-81EB-31F8AFE4B4D4Q38808084-D7E9C5AE-F56C-42BD-9B1B-21FB00A6A4ECQ40220518-88162984-DBEC-419F-BE21-96B88D580E46Q41105052-B9E4AA28-0A5C-446D-82EB-E3CFC997BBBEQ41676261-6F678DAC-2AD9-42C0-9DA6-D19AA1EE53ACQ47130816-B1F375C9-6182-4BAC-8338-3BD4AFEA3F4BQ55427825-CE665BE0-AB63-4EDE-97DC-BF8E9AAECA8CQ57452877-A6DA2826-3375-41F9-B434-4EA12166C466
P2860
A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A small-molecule blocking ribo ...... and overcomes drug resistance
@ast
A small-molecule blocking ribo ...... and overcomes drug resistance
@en
type
label
A small-molecule blocking ribo ...... and overcomes drug resistance
@ast
A small-molecule blocking ribo ...... and overcomes drug resistance
@en
prefLabel
A small-molecule blocking ribo ...... and overcomes drug resistance
@ast
A small-molecule blocking ribo ...... and overcomes drug resistance
@en
P2093
P2860
P1433
P1476
A small-molecule blocking ribo ...... and overcomes drug resistance
@en
P2093
Bingsen Zhou
D Lynne Smith
David Horne
M L Richard Yip
Shikha Gaur
Weidong Hu
Yate-Ching Yuan
P2860
P304
P356
10.1158/0008-5472.CAN-13-1094
P407
P577
2013-09-26T00:00:00Z